Jazz Pharmaceuticals plc (JAZZ)

Healthcare · Biotechnology · NASDAQ

Jazz Pharmaceuticals plc (JAZZ) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $16.65B, a trailing price-to-earnings ratio of 9.6 and a free-cash-flow yield of 7.3%. Over the most recent reported fiscal year, revenue grew 4.9% and free cash flow per share fell 8.0%.

Market cap	$16.65B
Trailing P/E	9.6
FCF yield	7.3%
Revenue growth (YoY)	+4.9%
EPS growth (YoY)	-61.3%
FCF/share growth (YoY)	-8.0%
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live JAZZ data on Nama Insights →

Recent Congressional trades

Jazz Pharmaceuticals plc trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Daniel Goldman	House	Sell	$15,001 - $50,000	Aug 9, 2023
Daniel Goldman	House	Buy	$15,001 - $50,000	Apr 3, 2023
Thomas Suozzi	House	Buy	$1,001 - $15,000	Oct 31, 2021